Twist Bioscience Shares Slide to Lowest in Two Years Following 4Q Loss

Dow Jones11-15

By Terell Wright

Shares Twist Bioscience 'retreated after the company posted a wider-than-expected quarterly loss and gave a revenue outlook with a midpoint below analyst expectations.

The stock was down 10% at $26.82 in midday trading on Friday. Shares fell at one point to $23.30 each, their lowest price since Dec. 1, 2023. For the year the stock is down 42%, and is on pace for its biggest one-day decline on a percentage basis since Aug. 2, 2024.

Twist reported before the market open a fourth-quarter loss of $27.1 million, or 45 cents a share, compared with a loss of $34.7 million, or 59 cents a share, in the same period a year earlier. While those numbers narrowed it missed analyst expectations for a loss of $25.8 million, or 42 cents a share, according to FactSet.

Sales rose nearly 17% to $99 million, above Wall Street's estimate of $97.3 million.

The company said it now expects full-year revenue of $425 million to $435 million, with the midpoint o below analysts' view for the year of $430.9 million.

Write to Terell Wright at terell.wright@wsj.com

(END) Dow Jones Newswires

November 14, 2025 12:20 ET (17:20 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2583668371?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-15 01:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2583668371","market":"hk","top_or_hot":-1,"title":"Twist Bioscience Shares Slide to Lowest in Two Years Following 4Q Loss","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Terell Wright \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares <a href=\"https://laohu8.com/S/TWST\">Twist Bioscience</a> 'retreated after the company posted a wider-than-expected quarterly loss and gave a revenue outlook with a midpoint below analyst expectations. \n</p>\n<p>\n  The stock was down 10% at $26.82 in midday trading on Friday. Shares fell at one point to $23.30 each, their lowest price since Dec. 1, 2023. For the year the stock is down 42%, and is on pace for its biggest one-day decline on a percentage basis since Aug. 2, 2024. \n</p>\n<p>\n  Twist reported before the market open a fourth-quarter loss of $27.1 million, or 45 cents a share, compared with a loss of $34.7 million, or 59 cents a share, in the same period a year earlier. While those numbers narrowed it missed analyst expectations for a loss of $25.8 million, or 42 cents a share, according to FactSet. \n</p>\n<p>\n  Sales rose nearly 17% to $99 million, above Wall Street's estimate of $97.3 million. \n</p>\n<p>\n  The company said it now expects full-year revenue of $425 million to $435 million, with the midpoint o below analysts' view for the year of $430.9 million. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Terell Wright at terell.wright@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 14, 2025 12:20 ET (17:20 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Twist Bioscience Shares Slide to Lowest in Two Years Following 4Q Loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTwist Bioscience Shares Slide to Lowest in Two Years Following 4Q Loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-11-15 01:20</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Terell Wright \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares <a href=\"https://laohu8.com/S/TWST\">Twist Bioscience</a> 'retreated after the company posted a wider-than-expected quarterly loss and gave a revenue outlook with a midpoint below analyst expectations. \n</p>\n<p>\n  The stock was down 10% at $26.82 in midday trading on Friday. Shares fell at one point to $23.30 each, their lowest price since Dec. 1, 2023. For the year the stock is down 42%, and is on pace for its biggest one-day decline on a percentage basis since Aug. 2, 2024. \n</p>\n<p>\n  Twist reported before the market open a fourth-quarter loss of $27.1 million, or 45 cents a share, compared with a loss of $34.7 million, or 59 cents a share, in the same period a year earlier. While those numbers narrowed it missed analyst expectations for a loss of $25.8 million, or 42 cents a share, according to FactSet. \n</p>\n<p>\n  Sales rose nearly 17% to $99 million, above Wall Street's estimate of $97.3 million. \n</p>\n<p>\n  The company said it now expects full-year revenue of $425 million to $435 million, with the midpoint o below analysts' view for the year of $430.9 million. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Terell Wright at terell.wright@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 14, 2025 12:20 ET (17:20 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2583668371","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2583668371","pubTimestamp":1763140800,"columns":[{"name":"Data Report","id":30,"label_key":"dataReport"}],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares Twist Bioscience 'retreated after the company posted a wider-than-expected quarterly loss and gave a revenue outlook with a midpoint below analyst expectations.The stock was down 10% at $26.82 in midday trading on Friday. Shares fell at one point to $23.30 each, their lowest price since Dec. 1, 2023. For the year the stock is down 42%, and is on pace for its biggest one-day decline on a percentage basis since Aug. 2, 2024.Twist reported before the market open a fourth-quarter loss of $27.1 million, or 45 cents a share, compared with a loss of $34.7 million, or 59 cents a share, in the same period a year earlier. While those numbers narrowed it missed analyst expectations for a loss of $25.8 million, or 42 cents a share, according to FactSet.Sales rose nearly 17% to $99 million, above Wall Street's estimate of $97.3 million.The company said it now expects full-year revenue of $425 million to $435 million, with the midpoint o below analysts' view for the year of $430.9 million.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4139":"生物科技","BK4585":"ETF&股票定投概念","TWST":"Twist Bioscience Corp"},"translate_title":"第四季度亏损后，Twist Bioscience股价跌至两年来最低水平","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":0.9},"content_text":"By Terell Wright \n\n\n \n\n\n  Shares Twist Bioscience 'retreated after the company posted a wider-than-expected quarterly loss and gave a revenue outlook with a midpoint below analyst expectations. \n\n\n  The stock was down 10% at $26.82 in midday trading on Friday. Shares fell at one point to $23.30 each, their lowest price since Dec. 1, 2023. For the year the stock is down 42%, and is on pace for its biggest one-day decline on a percentage basis since Aug. 2, 2024. \n\n\n  Twist reported before the market open a fourth-quarter loss of $27.1 million, or 45 cents a share, compared with a loss of $34.7 million, or 59 cents a share, in the same period a year earlier. While those numbers narrowed it missed analyst expectations for a loss of $25.8 million, or 42 cents a share, according to FactSet. \n\n\n  Sales rose nearly 17% to $99 million, above Wall Street's estimate of $97.3 million. \n\n\n  The company said it now expects full-year revenue of $425 million to $435 million, with the midpoint o below analysts' view for the year of $430.9 million. \n\n\n \n\n\n  Write to Terell Wright at terell.wright@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 14, 2025 12:20 ET (17:20 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2583668371","isCrawlerRequest":true}